Resonance Health LtdASX: RHT

Liver Fibrosis Device Webinar Presentation

· Issued by Resonance Health Ltd

Filed with ASX · · 31 pages · English

Summary by 6ix AI

Resonance Health Ltd has released preliminary results from its MRI Liver Fibrosis Device clinical trial, which will be discussed in an upcoming webinar. These preliminary findings are subject to further analysis and independent verification, emphasizing the investigational nature of the device.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Resonance Health Ltd on 6ix

Earlier from Resonance Health

Later from Resonance Health

All Resonance Health news releases